Abstract
Purpose
To retrospectively evaluate the clinical outcomes of cryoablation for secondary renal cell carcinoma for patients with a history of nephrectomy for initial renal cell carcinoma.
Materials and Methods
Thirty patients with 40 renal tumors who had undergone a nephrectomy for initial renal cell carcinoma and cryoablation for renal cell carcinoma as a secondary treatment during the period from April 2014 to December 2018 at a single center institution were enrolled. The patients' overall survival, local control, relapse-free survival, change of renal function, and complications were evaluated. The clinical factors of relapse-free survival were also evaluated.
Results
The 5 year overall survival rate was 94.5%, the 5 year local control rate was 89.3%, and the 5 year relapse-free survival rate (RFSR) was 56.3%. There was an average reduction in renal function of 8.5% after 1 year, and > grade 3 complications occurred in only one case. The RFSR in the patients whose initial stage was T3 was 0%, significantly lower than the 70.4% RFSR in the patients whose initial stage was T1 or T2.
Conclusion
Cryoablation for secondary renal cell carcinoma after nephrectomy was safe and provided good local control with preserved renal function. However, the indications for cryoablation should be carefully considered for patients with T3-stage initial renal cell carcinoma, because of the high risk of relapse.
Level of evidence
III
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Fergany AF, Hafez KS, Novick AC. Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year follow-up. J Urol. 2000;163(2):442–5.
Choi JE, You JH, Kim DK, Rha KH, Lee SH. Comparison of perioperative outcomes between robotic and laparoscopic partial nephrectomy: a systematic review and meta-analysis. Eur Urol. 2015;67:891–901.
Uhlig J, Strauss A, Rücker G, et al. Partial nephrectomy versus ablative techniques for small renal masses: a systematic review and network meta-analysis. Eur Radiol. 2019;29(3):1293–307.
Yoshimatsu R, Yamagami T, Nishimori M, et al. Time-dependent effects of cryoablation for renal tumor on overall and split renal function. J Vasc Interv Radiol. 2019;30(3):460–5.
Long JA, Bernhard JC, Bigot P, et al. Partial nephrectomy versus ablative therapy for the treatment of renal tumors in an imperative setting. World J Urol. 2017;35(4):649–56.
Zhou W, Uppot RN, Feldman AS, Arellano RS. Percutaneous image-guided thermal ablation for multifocal renal cell carcinoma: 10 year experience at a single center. AJR Am J Roentgenol. 2017;209(4):733–9.
Jacqmin D, Saussine C, Roca D, Roy C, Bollack C. Multiple tumors in the same kidney: incidence and therapeutic implications. Eur Urol. 1992;21:32–4.
Maurice M, Ramirez D, Nelson R, et al. Multiple tumor excisions in ipsilateral kidney increase complications after partial nephrectomy. J Endourol. 2016;30:1200–6.
Nick WL, Kiranpreet K, Sunil S, et al. Repeat partial nephrectomy on the solitary kidney: surgical, functional, and oncologic outcomes. J Urol. 2010;183(5):1719–24.
Ryan MH, Grant DS, Stephen AB, et al. Percutaneous renal cryoablation after partial nephrectomy: technical feasibility, complications and outcomes. J Urol. 2013;189(4):1243–8.
Adam JW, Thomas DA, Igor F, et al. Percutaneous cryoablation of masses in a solitary kidney. AJR Am J Roentgenol. 2010;194:1620–5.
Zhou W, Herwald SE, Uppot RN, Arellano RS. Image-guided thermal ablation for non-resectable recurrence of renal cell cancer following nephrectomy: clinical experience with eleven patients. Cardiovasc Interv Radiol. 2018;41(11):1743–50.
David JB, Alexander JK, Nirav P, Richard L, Matthew H. Image-guided cryoablation for sporadic renal cell carcinoma: three- and 5 year outcomes in 220 patients with biopsy-proven renal cell carcinoma. Radiol. 2018;289:554–61.
Palumbo C, Cyr SJ, Mazzone EJ, et al. Impact of tumor size on cancer-specific mortality rate after local tumor ablation in T1a renal-cell carcinoma. Endourol. 2019;33(7):606–13.
Rodriguez R, Cizman Z, Hong K, Koliatsos A, Georgiades C. Prospective analysis of the safety and efficacy of percutaneous cryoablation for pT1NxMx biopsy-proven renal cell carcinoma. Cardiovasc Interv Radiol. 2011;34(3):573–8.
Wehrenberg-Klee E, Clark T, Malkowicz S, et al. Impact on renal function of percutaneous thermal ablation of renal masses in patients with preexisting chronic kidney disease. J Vasc Interv Radiol. 2012;23(1):41–5.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Consent for Publication
For this type of study consent for publication is not required.
Ethical Approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. For this type of study formal consent is not required.
Informed Consent
This study has obtained IRB approval from Kyushu University, and the need for informed consent was waived.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ushijima, Y., Asayama, Y., Nishie, A. et al. Cryoablation for Secondary Renal Cell Carcinoma After Surgical Nephrectomy. Cardiovasc Intervent Radiol 44, 414–420 (2021). https://doi.org/10.1007/s00270-020-02709-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-020-02709-w